Clinical Trial Update: A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing neoadjuvant chemoimmunotherapy and immuno-consolidation after radical chemoradiotherapy for stage III potentially resectable non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Zeng Jian | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING